

In 2016, the International Association for the Study of Pain (IASP) introduced the term “nociplastic pain” this pain is mechanically distinct from the nociceptive and neuropathic types of pain. FM and its comorbidities negatively impact daily activities and health- related quality of life (HRQoL) they impose a major socioeconomic burden on healthcare systems and patients. Despite the high prevalence of FM, diagnosis often requires more than 2 years patients see an average of 3.7 different physicians during that time.

The prevalence of FM is estimated to be 1%∼5% in the general population it varies depending on the diagnostic criteria applied. Fibromyalgia (FM) is a chronic, complex disorder characterized by widespread musculoskeletal pain and various associated symptoms (e.g., fatigue, sleep fragmentation, depressed mood, and anxiety).
